MedPath

Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm)

Not Applicable
Completed
Conditions
Open Angle Glaucoma
Interventions
Procedure: lasertrabeculoplasty
Registration Number
NCT01788319
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Brief Summary

This study will investigate if micropulse laser trabeculoplasty (532nm) is as effecttive as or better than the conventional laser trabeculoplasty (532nm), it might be a new treatment strategy for glaucoma patients. It is done with a laser device that can also be used for many other ophthalmic applications, thus reducing the economic burden of treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • individuals over 18 years old
  • willing to sign an informed consent and able to comply the requirements of the study
  • having no other ocular diseases besides glaucoma
Exclusion Criteria
  • history of ocular trauma
  • intraocular surgery (except for phaco)
  • pigment dispersion and exfoliation glaucoma

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
lasertrabeculoplastylasertrabeculoplasty-
Primary Outcome Measures
NameTimeMethod
to compare the intraocular pressure reduction with the micropulse laser trabeculoplasty (532nm) versus the conventional laser trabeculoplasty (532nm)one year of follow-up
Secondary Outcome Measures
NameTimeMethod
Secondary the complication rate between the two techniques will be comparedone year of follow up

Trial Locations

Locations (1)

Department of Ophthalmology, UZLeuven

🇧🇪

Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath